Target intelligence / Profile preview

RNA, U6 small nuclear 999, pseudogene (RNU6-999P)

Target
RNU6-999P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RNA, U6 small nuclear 999, pseudogene (RNU6-999P) is a processed pseudogene related to U6 small nuclear RNA genes. While functional U6 snRNAs are integral non-coding RNAs essential for splicing of pre-mRNA as part of the spliceosome[1][3], U6-derived pseudogenes do not encode functional RNA products and are not directly involved in RNA splicing. Instead, like other pseudogenes, RNU6-999P may be transcribed without producing functional protein or RNA, and could potentially have regulatory roles, such as acting as a miRNA "decoy" or generating endogenous siRNAs[6][8]. However, there is no direct evidence that RNU6-999P itself has a specific biological or disease function, nor is it a therapeutic target or druggable molecule[5]. Key clarifications: - RNU6-999P is not a protein, receptor, enzyme, or transporter. - It is not a therapeutic target and does not have associated drugs or mechanisms of action. - There is no evidence of biomarker utility, safety concerns, or direct disease relevance. - The entry is "incorrect" as a canonical drug target due to its classification as a pseudogene and lack of direct functional or therapeutic relevance.

Other names
RNU6-999PRNA, U6 small nuclear 999, pseudogene
02

Biological functions

May participate in non-coding RNA regulationPotentially involved in gene expression regulation via siRNA/ceRNA mechanisms typical of pseudogenes[6][8]
03

Disease associations

No direct evidence for disease role for RNU6-999PSome pseudogenes influence disease pathways through competitive endogenous RNA or small RNA interference, but no direct data for this gene[6][8]

Beyond the preview

Go deeper on RNA, U6 small nuclear 999, pseudogene (RNU6-999P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 999, pseudogene (RNU6-999P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call